Core Insights - Arbiter, a startup founded by Michelle Carnahan, has raised $52 million in seed funding to create a platform that connects healthcare professionals and payers to enhance patient care [1][2] - The funding has been sourced from family offices, leading to a valuation of $400 million for Arbiter [2] - Arbiter aims to utilize AI to streamline interactions among payers, providers, and patients, with over 1,000 clinicians already engaged within six months of its launch [5] Company Background - Michelle Carnahan has extensive experience in healthcare, having worked at Eli Lilly for 26 years and later at Thirty Madison, where she played a key role in achieving a $1 billion valuation [3] - Thirty Madison was acquired by Remedy Meds in a $500 million all-stock deal in September [3] Funding Strategy - Carnahan intentionally chose to raise funds from specialized investors rather than traditional venture capital to expedite the product's market entry [4] - The partnership with family offices and the acquisition of SecondWave Delivery Systems have been pivotal in accelerating Arbiter's market presence [5][6] Mission and Vision - Arbiter's mission is to transform the U.S. healthcare system by aligning payers and providers to create a cohesive system that prioritizes patient needs [7]